Alleviating CGT bottlenecks: Standards needed to ensure volumes, quality of starting material 12-Nov-2021 By Jane Byrne Be the Match BioTherapies (BTMB) says it is critical that resilient cell sourcing infrastructures exist when cell and gene therapies (CGT) surge to market.
Be The Match and TrakCel partner on integrated services for cell therapy developers 24-Jun-2019 By Vassia Barba Be The Match BioTherapies and TrakCel form a strategic partnership to integrate their offering for companies developing cell and gene therapies.